For many years, developmental and physiological differences have been known to exist between anatomic segments of the colorectum. Because of different outcomes, prognoses, and clinical responses to chemotherapy, the distinction between right colon cancer (RCC) and left colon cancer (LCC) has gained attention. Furthermore, variations in the molecular features and gut microbiota between right and LCCs have recently been a hot research topic. CpG island methylator phenotype-high, microsatellite instability-high colorectal cancers are more likely to occur on the right side whereas tumors with chromosomal instability have been detected in approximately 75% of LCC patients and 30% of RCC patients. The mutation rates of oncogenes and tumor suppressor genes also differ between RCC and LCC patients. Biofilm is more abundant in RCC patients than LLC patients, as are Prevotella, Selenomonas, and Peptostreptococcus. Conversely, Fusobacterium, Escherichia/Shigella, and Leptotrichia are more abundant in LCC patients compared to RCC patients. Distinctive characteristics are apparent in terms of molecular features and gut microbiota between right and LCC. However, how or to what extent these differences influence diverging oncologic outcomes remains unclear. Further clinical and translational studies are needed to elucidate the causative relationship between primary tumor location and prognosis.
Citations
Citations to this article as recorded by
Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients Jae-Ghi Lee, Ilkyu Park, Hannah Lee, Seungyoon Nam, Jisup Kim, Won-Suk Lee, Myunghee Kang, Jung Ho Kim BMC Cancer.2025;[Epub] CrossRef
The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions Imen Zalila-Kolsi, Dhoha Dhieb, Hussam A. Osman, Hadjer Mekideche Biology.2025; 14(3): 251. CrossRef
The gut microbiota and its biogeography Giselle McCallum, Carolina Tropini Nature Reviews Microbiology.2024; 22(2): 105. CrossRef
The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer Forough Masheghati, Mohammad Reza Asgharzadeh, Abbas Jafari, Naser Masoudi, Hadi Maleki-Kakelar Life Sciences.2024; 344: 122529. CrossRef
Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer Mutebi John Kenneth, Hsin-Chi Tsai, Chuan-Yin Fang, Bashir Hussain, Yi-Chou Chiu, Bing-Mu Hsu Journal of Advanced Research.2023; 52: 45. CrossRef
Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer Jiahui Feng, Zhizhong Gong, Zhangran Sun, Juan Li, Na Xu, Rick F. Thorne, Xu Dong Zhang, Xiaoying Liu, Gang Liu Frontiers in Microbiology.2023;[Epub] CrossRef
Metachronous Colorectal Adenomas Occur Close to the Index Lesion Ria Rosser, Bernard M. Corfe, Keith S. Chapple Journal of Clinical Gastroenterology.2023; 57(9): 937. CrossRef
Genetic heterogeneity of colorectal cancer and the microbiome Marina A Senchukova World Journal of Gastrointestinal Oncology.2023; 15(3): 443. CrossRef
Impact of Colorectal Cancer Sidedness and Location on Therapy and Clinical Outcomes: Role of Blood-Based Biopsy for Personalized Treatment Sasha Waldstein, Marianne Spengler, Iryna V. Pinchuk, Nelson S. Yee Journal of Personalized Medicine.2023; 13(7): 1114. CrossRef
Fusobacterium nucleatum-Mediated Alteration in Expression of VEGF and CCL3 Genes and KRAS Mutation in Colorectal Cancer Patients Hataw Jalal Taher, Fouad Kamel Jundishapur Journal of Microbiology.2023;[Epub] CrossRef
Risk of developing metachronous colorectal neoplasia after the resection of proximal versus distal adenomas Yoon Suk Jung, Nam Hee Kim, Youngwoo Kim, Dong Il Park Digestive and Liver Disease.2022; 54(4): 537. CrossRef
Faeces from malnourished colorectal cancer patients accelerate cancer progression Xu Chao, Zhang Lei, Liu Hongqin, Wang Ziwei, Li Dechuan, Du Weidong, Xu Lu, Chen Haitao, Zhang Bo, Ju Haixing, Yao Qinghua Clinical Nutrition.2022; 41(3): 632. CrossRef
Clinical and molecular profile of young adults with early‐onset colorectal cancer: Experience from four Australian tertiary centers Derrick Ho Wai Siu, Arwa Ali, Angelina Tjokrowidjaja, Madhawa De Silva, Joanna Lee, Philip R. Clingan, Morteza Aghmesheh, Daniel Brungs, Cristina Mapagu, David Goldstein, Siobhan O'Neill, Winston S. Liauw, Katrin M. Sjoquist, David Thomas, Nick Pavlakis, Asia-Pacific Journal of Clinical Oncology.2022; 18(6): 660. CrossRef
Microbial Characteristics of Common Tongue Coatings in Patients with Precancerous Lesions of the Upper Gastrointestinal Tract Xiaoyu Kang, Bin Lu, Pan Xiao, Zhaolai Hua, Rui Shen, Jianping Wu, Juan Wu, Zhenfeng Wu, Chun Cheng, Junfeng Zhang, Enas Abdulhay Journal of Healthcare Engineering.2022; 2022: 1. CrossRef
Colorectal microbiota after removal of colorectal cancer Peter Cronin, Clodagh L Murphy, Maurice Barrett, Tarini Shankar Ghosh, Paola Pellanda, Eibhlis M O’Connor, Syed Akbar Zulquernain, Shane Kileen, Morgan McCourt, Emmet Andrews, Micheal G O’Riordain, Fergus Shanahan, Paul W O’Toole NAR Cancer.2022;[Epub] CrossRef
Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer Sanghyun An, Hongjin Shim, Kwangmin Kim, Bora Kim, Hui-Jae Bang, Hyejin Do, Hyang-Rae Lee, Youngwan Kim Annals of Coloproctology.2022; 38(2): 97. CrossRef
Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance] B. Saberzadeh-Ardestani, N.R. Foster, H.E. Lee, Q. Shi, S.R. Alberts, T.C. Smyrk, F.A. Sinicrope Annals of Oncology.2022; 33(11): 1159. CrossRef
Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids Luiza Holst, Cristina Iribarren, Maria Sapnara, Otto Savolainen, Hans Törnblom, Yvonne Wettergren, Hans Strid, Magnus Simrén, Maria K. Magnusson, Lena Öhman International Journal of Molecular Sciences.2022; 23(24): 15505. CrossRef
Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer Esmeralda C. Marginean, Joanna Gotfrit, Horia Marginean, Daniel W. Yokom, Justin J. Bateman, Manijeh Daneshmand, Shelly Sud, Allen M. Gown, Derek Jonker, Timothy Asmis, Rachel A. Goodwin Translational Oncology.2021; 14(2): 100996. CrossRef
Construction of a long noncoding RNA-based competing endogenous RNA network and prognostic signatures of left- and right-side colon cancer Ke-zhi Li, Yi-xin Yin, Yan-ping Tang, Long Long, Ming-zhi Xie, Ji-lin Li, Ke Ding, Bang-li Hu Cancer Cell International.2021;[Epub] CrossRef
Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer Julie Veziant, Romain Villéger, Nicolas Barnich, Mathilde Bonnet Cancers.2021; 13(9): 2215. CrossRef
Association of Habitual Preoperative Dietary Fiber Intake With Complications After Colorectal Cancer Surgery Dieuwertje E. Kok, Melissa N. N. Arron, Tess Huibregtse, Flip M. Kruyt, Dirk Jan Bac, Henk K. van Halteren, Ewout A. Kouwenhoven, Evertine Wesselink, Renate M. Winkels, Moniek van Zutphen, Fränzel J. B. van Duijnhoven, Johannes H. W. de Wilt, Ellen Kampma JAMA Surgery.2021; 156(9): 827. CrossRef
Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies Andreas Koulouris, Christos Tsagkaris, Ippokratis Messaritakis, Nikolaos Gouvas, Maria Sfakianaki, Maria Trypaki, Vasiliki Spyrou, Manousos Christodoulakis, Elias Athanasakis, Evangelos Xynos, Maria Tzardi, Dimitrios Mavroudis, John Souglakos Cancers.2021; 13(14): 3522. CrossRef
Effects of Helicobacter pylori Infection on the Oral Microbiota of Reflux Esophagitis Patients Tian Liang, Fang Liu, Lijun Liu, Zhiying Zhang, Wenxue Dong, Su Bai, Lifeng Ma, Longli Kang Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies Kevin M. Tourelle, Sebastien Boutin, Markus A. Weigand, Felix C. F. Schmitt Biomedicines.2021; 9(10): 1305. CrossRef
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4 Naroa Serna, José Vicente Carratalá, Oscar Conchillo-Solé, Carlos Martínez-Torró, Ugutz Unzueta, Ramón Mangues, Neus Ferrer-Miralles, Xavier Daura, Esther Vázquez, Antonio Villaverde Pharmaceutics.2021; 13(11): 1922. CrossRef
Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future Murdani Abdullah, Ninik Sukartini, Saskia Aziza Nursyirwan, Rabbinu Rangga Pribadi, Hasan Maulahela, Amanda Pitarini Utari, Virly Nanda Muzellina, Agustinus Wiraatmadja, Kaka Renaldi Digestion.2021; 102(6): 823. CrossRef
The gut microbiome in epilepsy Birol Şafak, Bengü Altunan, Birol Topçu, Aynur Eren Topkaya Microbial Pathogenesis.2020; 139: 103853. CrossRef
Therapeutic Targeting of the Colorectal Tumor Stroma Wolf H. Fridman, Ian Miller, Catherine Sautès-Fridman, Annette T. Byrne Gastroenterology.2020; 158(2): 303. CrossRef
Bacterial Biofilm and its Role in the Pathogenesis of Disease Lene K. Vestby, Torstein Grønseth, Roger Simm, Live L. Nesse Antibiotics.2020; 9(2): 59. CrossRef
Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer Siyang Xu, Wen Yin, Yuling Zhang, Qimei Lv, Yijun Yang, Jin He Cancers.2020; 12(2): 372. CrossRef
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma Loris Riccardo Lopetuso, Marco Severgnini, Silvia Pecere, Francesca Romana Ponziani, Ivo Boskoski, Alberto Larghi, Gianluca Quaranta, Luca Masucci, Gianluca Ianiro, Tania Camboni, Antonio Gasbarrini, Guido Costamagna, Clarissa Consolandi, Giovanni Cammaro PLOS ONE.2020; 15(5): e0231789. CrossRef
Unsuspected clinical presentation of coronavirus disease 2019: acute bowel disease Marco Lotti, Michela Giulii Capponi, Dusanka Dokic, Paolo Bertoli, Alessandro Lucianetti ANZ Journal of Surgery.2020; 90(9): 1772. CrossRef
Does Sidedness Matter in Unresectable Colorectal Cancer? Suneel D. Kamath, Alok A. Khorana Annals of Surgical Oncology.2019; 26(6): 1588. CrossRef
Morphological characteristics of mucinous adenocarcinoma of the colon and its embryogenetic premises Yu. S. Korneva, R. V. Ukrainets Colorectal Oncology.2019; 9(2): 16. CrossRef
Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients Xia-Hong You, Can Wen, Zi-Jin Xia, Fan Sun, Yao Li, Wei Wang, Zhou Fang, Qing-Gen Chen, Lei Zhang, Yu-Huang Jiang, Xiao-Zhong Wang, Hou-Qun Ying, Zhen Zong Frontiers in Oncology.2019;[Epub] CrossRef
Endoscopic gastric mucosal atrophy as a predictor of colorectal polyps: a large scale case-control study Yoshinari Kawahara, Masaaki Kodama, Kazuhiro Mizukami, Tomoko Saito, Yuka Hirashita, Akira Sonoda, Kensuke Fukuda, Osamu Matsunari, Kazuhisa Okamoto, Ryo Ogawa, Tadayoshi Okimoto, Kazunari Murakami Journal of Clinical Biochemistry and Nutrition.2019; 65(2): 153. CrossRef
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer Sally Temraz, Farah Nassar, Rihab Nasr, Maya Charafeddine, Deborah Mukherji, Ali Shamseddine International Journal of Molecular Sciences.2019; 20(17): 4155. CrossRef